SPOTLIGHT -
Wavefront-guided procedures can reduce residual myopia, astigmatism, subjective complaints
Gene editing untangles one strand of the AMD web
(EyePod) From idea to impact: Navigating ophthalmic innovation
WVU Medicine to expand, relocate WVU Eye Institute
EyePod: Modifier Gene Therapy: What is it?
Ocugen completes dosing of subjects with geographic atrophy in Cohort 2 of Phase 1/2 ArMaDa clinical trial of OCU410
ARVO flying high in Seattle